Oculistica

Responsabile: Prof. Luca Buzzonetti


Location: Roma Gianicolo - Roma San Paolo - Palidoro - Santa Marinella

Tel. (+39) 06 6859.3357

L'UOC di Oculistica rappresenta il più importante Centro Nazionale per quanto riguarda i trapianti di cornea in età pediatrica. Ne vengono effettuati 20/25 l'anno.

 

La nostra struttura è l'unica dotata in campo pediatrico del Laser a Femtosecondi che rappresenta la tecnologia più avanzata in chirurgia corneale. Questa "expertise" viene riconosciuta anche a livello Internazionale, soprattutto, in relazione alla numerose pubblicazioni su riviste con impact factor. Stiamo sviluppando in collaborazione con il CNR di Firenze un progetto di ricerca relativo allo studio dello strato di DUA anche in cornee pediatriche. 

 

Abbiamo sviluppato e pubblicato nel 2015 una nuova tecnica di cheratoplastica lamellare anteriore denominata "Big Bubble full femto".

 

- Cataratta congenita

- Glaucoma congenito

- Retinopatia del pretermine

- Trapianti di Cornea

- Neoplasie dell'orbita e del bulbo oculare (Retinoblastoma e Rabdomiosarcoma)

- Riabilitazione visiva

- Genetica oculare

 

Medico

Catena Gino

Esposito Maria Cristina

Fortunato Michele 

Iarossi Giancarlo 

Maggi Riccardo 

Petrocelli Gianni

Petroni Sergio 

Romanzo Antonino

Turtoro Angela 

Valente Paola 

Zampini Andrea

Capozzi Paolo 

 

Director: Dr. Luca Buzzonetti

Referring physician for the portal: Dott. Antonino Romanzo

 

Rome (Gianicolo) - Giovanni Paolo II Pavilion

Tel. +39.06.6859.2222 +39.06.6859.3357

email: psp.oculistica@opbg.net

 

Palidoro – Via Torre di Palidoro (Fiumicino) – Paolo VI Pavilion

Tel. +39.06.6859.2222 +39.06.6859.3357

 

Attività

The Ophthalmology Clinic provides treatment and care to patients referred by their family doctor for routine eye examinations, vision problems (myopia, hyperopia, astigmatism) and patients with congenital disorders.  

About 23,000 visits are carried out each year.

 

Informazioni utili

Due to restoration work at the Gianicolo facility, the Ophthalmology Clinic has moved to the Giovanni Paolo II Pavilion, lower level -1 (former Diagnostic Laboratories)

 

The Clinics are located:

- Rome (Gianicolo): Gerini Pavilion

 

Open Monday to Friday, morning and afternoon; Saturday morning.

- Palidoro: Paolo VI Pavilion

 

Open Monday to Friday, 8:30 am - 2:30 pm; Wednesday and Thursday, 2:00 pm until all scheduled appointments have been completed.

 

To schedule an appointment call the CUP (Centralised Appointment Service): 06-68181.

 

Director: Dr. Michele Fortunato

Referring physician for the portal: Dott. Antonino Romanzo

 

Palidoro – Via Torre di Palidoro (Fiumicino) –Paolo VI Pavilion

Tel. (+39) 06-6859.3311 - 3256

Fax (+39) 06-6859.3281

email: psp.oculistica@opbg.net

 
Attività

The unit provides care for:

 

·         age-related macular degeneration (AMD);

 

·         hereditary degenerative disorders (Best disease);

 

·         retinal complications in myopia (subretinal neovascular membranes);

 

·         Coats' disease;

 

·         neovascularization secondary to choioretinitis. 

 

We treat these disorders with Photodynamic Therapy (PDT). This technique was introduced a few years ago and blocks the progression of the disease.

PDT, originally developed to treat age-related macular degeneration in adults, was used on children by OPBG specialists for the first time in the world, thereby radically changing prognoses, specifically for Best disease and Coats' disease.

 

The therapy uses Verteporfin, a photosensitizing agent that is administered intravenously and is activated with light to close up leaking blood vessels.

With light lasers, in contrast to laser therapy, there is no damage or scarring to the retina and it targets only the diseased vessels that cause serious vision and development problems.

The drug is administered by an anaesthesiologist who monitors patients and assists them in case of need. The drug is not toxic and the only side effect is sensitivity to light (skin rashes when exposed to sunlight). We therefore recommend that patients treated with PDT avoid exposure to sunlight for about three days.

Because it does not damage the retina, the procedure can be repeated. If used in a timely manner, PDT has been proven effective in 70% of the adults tested.

The prognosis seems even better for children.

The technique requires a simple topical anaesthesia on the cornea in order to place a contact lens.

Non-collaborative children will need general anaesthesia and be treated in an operating room.

 

Staff

Dr. Michele Fortunato

Dr. Antonino Romanzo

Dr. Eugenio Glorialanza

 

Mrs. Cinzia Di Felice 

Mrs. Rosina Montanaro  

Mrs. Donatella Virgili

 

Useful Information

How the treatment is performed:

 

·         The therapy is performed as an Inpatient procedure (48 hours) and is free of charge.

 

·         Two appointments a month are scheduled during which 4-6 treatments are carried out.

 

·         Patients that require PDT are treated as soon as possible in order to avoid further damage.

 

·         Patients can lead a normal lifestyle after discharge.

 

·         Fluorescein angiography and indocyanine green (ICG) testing are scheduled as outpatient procedures within one month of the treatment at the OPBG facility or in similar facilities where the patient resides.

 

Our specialised unit is a referral center for the Gruppo Italiano Terapia Fotodinamica (GIFT – Italian Group for Photodynamic Therapy) for paediatric care.

 

How to access the center

 

·         The center is part of the Division of Ophthalmology located at the Paolo VI Pavilion at the Ospedale Bambino Gesù Palidoro facility.

 

·         Inpatient hospitalisation and Clinic visits are carried out here.

 

To schedule an appointment: Tel. 06-6859.3311, 9:00 am – 2:00 pm.

 

Necessary diagnostic tests:

Before patients can receive the therapy, the following tests and exams are necessary:

 

·         Fluorescein angiography

 

·         Indocyanine green (ICG)

 

Treatment is performed using Photodynamic Therapy (PDT). This relatively new technique blocks the progression of the disease.